BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 44 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,514,056 | -2.3% | 17,855,000 | -20.1% | 0.59% | +7.5% |
| Q2 2023 | $13,838,372 | -38.4% | 22,355,000 | -36.8% | 0.55% | -37.5% |
| Q1 2023 | $22,459,155 | +53.9% | 35,355,000 | -10.2% | 0.88% | +54.3% |
| Q4 2022 | $14,590,746 | -16.0% | 39,355,000 | 0.0% | 0.57% | -15.0% |
| Q3 2022 | $17,370,000 | -3.9% | 39,355,000 | 0.0% | 0.67% | -7.5% |
| Q2 2022 | $18,072,000 | -4.3% | 39,355,000 | 0.0% | 0.72% | +22.6% |
| Q1 2022 | $18,879,000 | – | 39,355,000 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INHERENT GROUP, LP | 39,500,000 | $19,370,000 | 3.63% |
| Athyrium Capital Management, LP | 20,000,000 | $9,682,000 | 3.44% |
| Diameter Capital Partners LP | 65,894,000 | $31,800,000 | 1.48% |
| Affinity Asset Advisors, LLC | 10,000,000 | $4,680,000 | 0.75% |
| Context Capital Management, LLC | 22,958 | $11,209,000 | 0.73% |
| DeepCurrents Investment Group LLC | 39,355,000 | $18,879,000 | 0.59% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 5,000,000 | $2,373,000 | 0.53% |
| Aequim Alternative Investments LP | 35,000,000 | $16,380,000 | 0.43% |
| Antara Capital LP | 25,750,000 | $12,246,000 | 0.37% |
| ARISTEIA CAPITAL, L.L.C. | 31,816,000 | $15,472,000 | 0.28% |